Universitat Internacional de Catalunya
Other lecturers: Maria Fernández (mfernandezal@uic.es)
Questions will be resolved before or after class. To resolve non-face-to-face questions, this will be done by videoconference.
This course provides an applied perspective on entrepreneurship and innovation in the healthcare sector, focusing on how ideas emerging from biomedical research can become real-world solutions. It covers key development stages in biotech, medtech, and digital health, alongside support ecosystems, funding, regulation, and business models.
In addition, the course contributes to the Sustainable Development Goals (SDGs) of the 2030 Agenda, particularly SDGs 3, 9, 10, 12, and 17, through the promotion of health, people’s well-being, biomedical innovation, social equity, transparency in results, and strategic partnerships for scientific and social progress.
It is recommended to have passed Introduction to the Biomedical Company (2nd year).
Understand the full healthcare innovation cycle, from idea to market.
Identify entrepreneurship opportunities in biotech, medtech, and digital health.
Learn about key stakeholders, resources, and regulatory frameworks in biomedical innovation.
Apply practical tools to develop and validate innovative health projects.
Upon completing the course, students should be able to:
● Understand entrepreneurship strategies, including the use of business plans as working tools, and the role of bioincubators in knowledge transfer.
● Recognize the basic processes for creating companies in the academic environment (spin-offs), as well as the tools needed to manage them effectively.
● Describe the basic principles of business finance.
● Explain the basic principles of marketing, with special emphasis on product development processes.
● Define the basic principles governing startup law.
I. Introduction to Entrepreneurship and Innovation in Health
Definition and relevance of entrepreneurship in biomedicine
Innovation in pharma/biotech, medtech and digital health: similarities and differences
Life cycle of a biomedical project: from research to market
Key players in the health innovation ecosystem
Identifying problems and opportunities in scientific research
From lab to real-world application: assessing translational potential
Differences in opportunity identification across pharma/biotech, medtech and digital health
Initial validation: preclinical studies, proof of concept, and technical feasibility
Development roadmap by sector:
Pharma/Biotech: drug development and advanced therapies (preclinical and clinical trials)
Medtech: prototyping, safety testing, and certifications
Digital Health: software development, interoperability, and clinical validation
Intellectual property and innovation protection
Patent and copyright strategies
Licensing and technology transfer agreements
Regulation and compliance by sector
FDA, EMA and other regulatory bodies
ISO standards and medical certifications
Business models in pharma/biotech, medtech and digital health
Monetization and market access strategies
Licensing vs. internal development
Partnerships with pharma or tech companies
Reimbursement and outcome-based payment models
Market validation and go-to-market testing
Clinical adoption studies
Building user networks and early adopters
Funding sources for innovation projects
Grants and public funding
Venture capital, business angels, and corporate VC
Sector-specific funding models:
Pharma/Biotech: development deals, large investment rounds
Medtech: funding for prototyping and certification
Digital Health: staged funding and SaaS models
Investment strategies and market exit planning
Growth strategies by sector
Expansion in pharma and biotech markets
Growth of medtech startups and clinical validation
Scalability in digital health and adoption in health systems
Internationalization and access to global markets
Strategic partnerships and collaboration with corporates
1. Lectures – 20 hours: Faculty members share their knowledge in a classroom setting with the entire group of students.
2. Case Study Method (CM) – 10 hours: Students, in groups, solve clinical cases provided to them that day by the faculty. In the classroom, students present their conclusions with the active participation of the faculty, who can introduce new concepts whenever necessary.
1) Students in the first examination period:
Teaching staff reserve the right to add an extra 10% to the final grade based on subjective criteria such as engagement, participation, compliance with basic rules, etc.
2) Students in the second or subsequent examination period:
The continuous assessment grade (case study methods and lecture attendance) will be carried over from the first examination period; however, whenever desired, students may re-attend class to obtain a new grade in the 3rd or 5th examination period. The final project grade will NOT be carried over, and students must repeat and defend it for each failed examination period.
General points to keep in mind regarding the assessment system:
Shimasaki, C. D. (2014) – Biotechnology Entrepreneurship: Starting, Managing, and Leading Biotech Companies. Academic Press.
Wong, V. & Apfel, R. (2017) – MedTech Innovation and Entrepreneurship. CRC Press.
Robbins-Roth, C. (2001) – From Alchemy to IPO: The Business of Biotechnology. Perseus Publishing.
Blank, S. (2020) – The Startup Owner’s Manual: The Step-by-Step Guide for Building a Great Company. Wiley.